EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists

Vladimir M Pogorelov, Michael L Martini, Jian Jin iD, William C Wetsel, Marc G Caron

Biomolecules · 2023

DOI: 10.3390/biom13111658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Vladimir M Pogorelov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, 354 Sands Building, 303 Research Drive, Durham, NC 27710, USA. Hauptthemen laut MEDLINE: Dyskinesia, Drug-Induced, Parkinson Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

L-DOPA is the mainstay of treatment for Parkinson’s disease (PD). However, over time this drug can produce dyskinesia. A useful acute PD model for screening novel compounds for anti-parkinsonian and L-DOPA-induced dyskinesia (LID) are dopamine-depleted dopamine-transporter KO (DDD) mice. Treatment with α-methyl-para-tyrosine rapidly depletes their brain stores of DA and renders them akinetic. During sensitization in the open field (OF), their locomotion declines as vertical activities increase and upon encountering a wall they stand on one leg or tail and engage in climbing behavior termed “three-paw dyskinesia”. We have hypothesized that L-DOPA induces a stereotypic activation of locomotion in DDD mice, where they are unable to alter the course of their locomotion, and upon encountering walls engage in “three-paw dyskinesia” as reflected in vertical counts or beam-breaks. The purpose of our studies was to identify a valid index of LID in DDD mice that met three criteria: (a) sensitization with repeated L-DOPA administration, (b) insensitivity to a change in the test context, and (c) stimulatory or inhibitory responses to dopamine D1 receptor agonists (5 mg/kg SKF81297; 5 and 10 mg/kg MLM55-38, a novel compound) and amantadine (45 mg/kg), respectively. Responses were compared between the OF and a circular maze (CM) that did not hinder locomotion. We found vertical counts and climbing were specific for testing in the OF, while oral stereotypies were sensitized to L-DOPA in both the OF and CM and responded to D1R agonists and amantadine. Hence, in DDD mice oral stereotypies should be used as an index of LID in screening compounds for PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dyskinesia, Drug-InducedParkinson DiseaseMiceAnimalsLevodopaDopamine AgonistsDopamineDopamine Plasma Membrane Transport ProteinsMice, KnockoutAmantadine

Stichwörter der Autor:innen

L-DOPAParkinson’s diseasedopaminedopamine D1 agonistsdopamine transporter knockout micedyskinesia

Substanzen

LevodopaDopamine AgonistsDopamineDopamine Plasma Membrane Transport ProteinsAmantadine

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, 354 Sands Building, 303 Research Drive, Durham, NC 27710, USA.
  • Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.
  • Department of Neurobiology, Duke University Medical Center, Durham, NC 27710, USA.

ORCID-Profile: Jian Jin

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Pogorelov, V. M., Martini, M. L., Jin, J., Wetsel, W. C., & Caron, M. G. (2023). Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists. Biomolecules. https://doi.org/10.3390/biom13111658

Vancouver

Pogorelov VM, Martini ML, Jin J, Wetsel WC, Caron MG. Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists. Biomolecules. 2023. doi:10.3390/biom13111658

BibTeX
@article{Pogorelov2023,
  author = {Pogorelov, Vladimir M and Martini, Michael L and Jin, Jian and Wetsel, William C and Caron, Marc G},
  title = {Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13111658}
}
Kostenlos starten →